Sign in

You're signed outSign in or to get full access.

Megan Kennedy

Vice President at abrdn World Healthcare Fund
Executive

About Megan Kennedy

Megan Kennedy serves as Vice President and Secretary of abrdn World Healthcare Fund (THW) and the affiliated healthcare funds; she is also Senior Director, Product Governance at abrdn Inc. and has been with abrdn since 2005. She was born in 1974 and has served as an officer of the Funds since 2023; the proxy indicates officers are appointed annually by the Board. The proxy does not disclose executive-specific performance metrics (TSR, revenue, EBITDA) or fund-level bonus/equity plans for officers; officers are compensated by abrdn Inc., not by the Funds.

Past Roles

OrganizationRoleYearsStrategic impact
abrdn Inc.Senior Director, Product Governance2005–present (Officer of Funds since 2023) Product governance leadership for registered investment companies

Fixed Compensation

ComponentTHW fund disclosureNotes
Base salaryNot disclosed by THW; officers are employees of abrdn Inc. Compensation paid by abrdn Inc. (administrator/adviser), not by THW
Target bonus %Not disclosed at fund level Fund states no bonus/profit sharing plans
Actual bonus paidNot disclosed at fund level Fund states no bonus/profit sharing plans
Pension/SERPNone at the Fund; officers receive no Fund pension or retirement plans If any, would be at abrdn level; not disclosed in THW proxy
PerquisitesNot disclosed at fund level Officers are abrdn employees; fund does not report perquisites

Performance Compensation

MetricWeightingTargetActualPayoutVesting
Fund-level incentive metrics for officersNot disclosedNot disclosedNot disclosedNot disclosedNot disclosed
NotesOfficers are compensated by abrdn Inc.; the Funds disclose no officer bonus/profit sharing/equity plans at the fund level

Equity Ownership & Alignment

ItemDisclosure
Role-related ownershipIndividual officer holdings for Megan Kennedy are not disclosed in the proxy
Aggregate officer/trustee ownershipTrustees and officers, in the aggregate, owned less than 1% of THW’s outstanding equity as of April 1, 2025
Shares outstanding (context)THW had 39,849,957.6 shares outstanding as of the record date (April 7, 2025)
Vested vs. unvested sharesNot disclosed at the fund level
Options/RSUs (fund-level)Not disclosed; officers receive no compensation from the Fund
Pledging/hedgingNot disclosed
Ownership guidelinesNot disclosed at fund level

Employment Terms

TermDisclosure
Employment start in current roleOfficer of the Funds since 2023 (Vice President)
Secretary responsibilitiesServes as Secretary; proxy revocation notices directed to her as Secretary
Appointment/termOfficers hold positions until a successor is elected and qualified; appointed annually at a Board meeting
Contract term lengthNot disclosed
Severance provisionsNot disclosed at fund level
Change-of-controlNot disclosed at fund level
Clawbacks/gross-upsNot disclosed at fund level
Non-compete / non-solicitNot disclosed
Post-termination consultingNot disclosed

Investment Implications

  • Pay-for-performance alignment at the fund level is limited: officers receive no compensation from THW and the proxy discloses no fund-level bonus/equity programs for officers, implying incentives are set at abrdn Inc. rather than tied directly to THW performance. This reduces visibility into performance-linked pay for Megan Kennedy in THW filings.
  • Ownership alignment appears modest at the fund level: aggregate trustees and officers own less than 1% of THW shares; individual officer ownership, including for Megan Kennedy, is not disclosed, limiting “skin-in-the-game” insight and reducing predictable vest-related selling signals from fund awards.
  • Retention risk likely hinges on abrdn employment terms (not disclosed in THW filings) given annual officer appointments and abrdn-based compensation; fund-level severance/CoC economics are not provided.